• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

OSAKO Yoichi  大迫 洋一

ORCIDConnect your ORCID iD *help
Researcher Number 60793354
Affiliation (Current) 2025: 鹿児島大学, 医歯学域鹿児島大学病院, 助教
Affiliation (based on the past Project Information) *help 2024: 鹿児島大学, 医歯学域鹿児島大学病院, 助教
2021: 鹿児島大学, 鹿児島大学病院, 医員
2020 – 2021: 鹿児島大学, 医歯学総合研究科, 客員研究員
2019: 鹿児島大学, 鹿児島大学病院, 医員
Review Section/Research Field
Principal Investigator
Basic Section 56030:Urology-related
Except Principal Investigator
Basic Section 56030:Urology-related
Keywords
Principal Investigator
腎癌 / メチル化 / セリン / 治療抵抗性 / PHGDH / 膀胱癌
Except Principal Investigator
抗癌剤耐性 / WDR62 / miR-223 / PHGDH … More / SMARCD1 / miR-99a-5p / 膀胱癌 / ジェムシタビン耐性 / ジェムシタビン / シスプラチン / マイクロRNA / 薬剤耐性 / 尿路上皮癌 Less
  • Research Projects

    (3 results)
  • Research Products

    (7 results)
  • Co-Researchers

    (3 People)
  •  治療抵抗性腎癌におけるSCG2を介した代謝リプログラミングの解明と新規治療戦略の開発Principal Investigator

    • Principal Investigator
      大迫 洋一
    • Project Period (FY)
      2024 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kagoshima University
  •  Targeting the Serine Synthesis Pathway as a Potential Novel Bladder Cancer Therapy and the elucidation of its Expression MechanismPrincipal Investigator

    • Principal Investigator
      OSAKO Yoichi
    • Project Period (FY)
      2020 – 2021
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kagoshima University
  •  Elucidating anticancer drug resistance in urothelial carcinoma by multi-faceted approach

    • Principal Investigator
      NAKAGAWA Masayuki
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kagoshima University

All 2022 2021 2020 2019

All Journal Article Presentation

  • [Journal Article] microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.2022

    • Author(s)
      Motoki Tamai, Shuichi Tatarano, Shunsuke Okamura, Wataru Fukumoto, Issei Kawakami, Yoichi Osako, Takashi Sakaguchi, Satoshi Sugita, Masaya Yonemori, Yasutoshi Yamada, Masayuki Nakagawa, Hideki Enokida, Hirofumi Yoshino.
    • Journal Title

      Molecular Oncology

      Volume: 16 Issue: 6 Pages: 1329-1346

    • DOI

      10.1002/1878-0261.13192

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09715, KAKENHI-PROJECT-20K18146, KAKENHI-PROJECT-21K09404, KAKENHI-PROJECT-22K09452, KAKENHI-PROJECT-22K09478
  • [Journal Article] EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer2021

    • Author(s)
      Okamura Shunsuke、Yoshino Hirofumi、Kuroshima Kazuki、Tsuruda Masafumi、Osako Yoichi、Sakaguchi Takashi、Yonemori Masaya、Yamada Yasutoshi、Tatarano Shuichi、Nakagawa Masayuki、Enokida Hideki
    • Journal Title

      BMC Cancer

      Volume: 21 Issue: 1 Pages: 48-48

    • DOI

      10.1186/s12885-020-07717-0

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K18146, KAKENHI-PROJECT-18K09198, KAKENHI-PROJECT-19K18615
  • [Journal Article] Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation2020

    • Author(s)
      Hirofumi Yoshino, Hideki Enokida, Yoichi Osako, Nijiro Nohata, Masaya Yonemori, Satoshi Sugita, Kazuki Kuroshima, Masafumi Tsuruda, Shuichi Tatarano, Masayuki Nakagawa.
    • Journal Title

      Molecular Oncology

      Volume: 54 Issue: 9 Pages: 2190-2202

    • DOI

      10.1002/1878-0261.12697

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09715, KAKENHI-PROJECT-20K18146, KAKENHI-PROJECT-18K09198, KAKENHI-PROJECT-19K18615
  • [Journal Article] Tumor suppressive microRNA223 targets WDR62 directly in bladder cancer.2019

    • Author(s)
      Sugita S, Yoshino H, Yonemori M, Miyamoto K, Matsushita R, Sakaguchi T, Itesako T, Tatarano S, Nakagawa M, Enokida H.
    • Journal Title

      Int J Oncol.

      Volume: 54 Pages: 2222-2236

    • DOI

      10.3892/ijo.2019.4762

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17H04332, KAKENHI-PROJECT-17K16799, KAKENHI-PROJECT-19K07736, KAKENHI-PROJECT-19K09715, KAKENHI-PROJECT-19K18615
  • [Presentation] PHGDHを標的とした新規膀胱癌治療の可能性とその発現機構の解明2021

    • Author(s)
      吉野裕史, 大迫洋一, 鶴田雅史, 黒島和樹, 岡村俊介, 榎田英樹, 中川昌之.
    • Organizer
      第30回泌尿器科分子・細胞研究会
    • Data Source
      KAKENHI-PROJECT-20K18146
  • [Presentation] PHGDHを標的とした新規膀胱癌治療の可能性とその発現機構の解明2021

    • Author(s)
      吉野裕史、大迫洋一、鶴田雅史、黒島和樹、岡村俊介、榎田英樹、中川昌之
    • Organizer
      第109回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-20K18146
  • [Presentation] シスプラチン耐性膀胱癌に対する治療標的型microRNAと標的遺伝子の探索2020

    • Author(s)
      岡村 俊介, 吉野 裕史, 大迫 洋一, 黒島 和樹, 鶴田 雅史, 榎田 英樹, 中川 昌之.
    • Organizer
      第108回日本泌尿器科学会総会
    • Data Source
      KAKENHI-PROJECT-20K18146
  • 1.  NAKAGAWA Masayuki (90164144)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 2.  榎田 英樹 (80347103)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results
  • 3.  吉野 裕史 (90642611)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 3 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi